C11: BEST-CLI and BASIL 2: Debate, Analysis and Implementation

Moderator(s)

• 

  Joseph Mills, Sr., MD

  Professor and Chief
  Baylor College of Medicine
  Houston, Texas

  Video Recording
• AF

  Alik Farber, MD, MBA

  Professor of Surgery and Radiology
  Boston University, Chobanian & Avedisian School of Medicine
  Boston, Massachusetts
• MM

  Matthew Menard, MD

  Associate Professor of Surgery
  Brigham and Women's Hospital / Harvard Medical School
  Boston, Massachusetts

Presentations:

• 3:30 PM – 3:37 PM ET

  Summary of BEST-CLI: Salient Findings
  

  Speaker: Alik Farber, MD, MBA – Boston University, Chobanian & Avedisian School of Medicine
• 3:37 PM – 3:44 PM ET

  Trial Limitations: How Limiting are They?
  

  Speaker: Matthew T. Menard, MD – Brigham and Women's Hospital / Harvard Medical School
• 3:44 PM – 3:51 PM ET

  Summary of BASIL 2: Salient Findings
  

  Speaker: Andrew W. Bradbury, MD, MBA (he/him/his) – University of Birmingham
• 3:51 PM – 3:58 PM ET

  Debate: Patients with CLTI Who Have Adequate Saphenous Vein Should be Treated with Bypass
  

  Speaker: Michael S. Conte, MD – University of California San Francisco
• 3:58 PM – 4:05 PM ET

  Debate: Almost all Patients with CLTI Should be First Treated with Endovascular Therapy
  

  Speaker: Brian G. DeRubertis, MD – Weill Cornell Medicine, Division of Vascular & Endovascular Surgery
• 4:05 PM – 4:12 PM ET

  Endpoints in BEST-CLI and BASIL 2: How Best to Capture Meaning
  

  Speaker: Vincent L. Rowe, MD (he/him/his) – Keck School of Medicine of University of Southern California
• 4:12 PM – 4:19 PM ET

  Administrative Database or Randomized Trial: What is BEST for CLTI?
  

  Speaker: Misty D. Humphries, MD, MS – University of California Davis
• 4:19 PM – 4:26 PM ET

  Implementing BEST-CLI and BASIL 2: What Will Be Easy and What Will Not
  

  Speaker: Kristina A. Giles – Department of Surgery, Division of Vascular Surgery, Maine Medical Center
• 4:26 PM – 5:00 PM ET

  Panel Discussion